In part 1 of this video series, David Ilson, MD, PhD, reviews recent immunotherapy updates in GEJ/gastric cancer.
In part 2 of this video series, David Ilson, MD, PhD, discusses approvals and advancements in the immunotherapy space for GEJ/GI cancer.
In part 2 of this series, Andrea Cercek, MD, discusses the clinical findings, molecular drivers/alterations, and further research for "Early On-Set Colorectal Cancer: A Biologically Distinct Threat…
In part 1 of this video series, Andrea Cercek, MD, discusses the background and possible association of hereditary/environmental factors in early-onset CRC.
Zev Wainberg, MD, and Anindo Chatterjee, MS, PhD, discuss the importance of preplanning sequential gastric cancer therapies from a new animated perspective.
Julio Garcia-Aguilar, MD, PhD, provided insight on how nonoperative management of rectal cancer is evolving at the virtual 2020 Great Debates & Updates in Gastrointestinal Malignancies meeting.
Dr Shroff highlights novel and targeted biliary cancer therapies at the virtual 2020 Great Debates & Updates in GI Malignancies meeting.
David Ilson, MD, PhD, discusses immunotherapy trial data as well as treatment debates in the esophageal and GEJ cancer space, at the virtual 2020 Great Debates and Updates in GI Malignancies meeting.
Stay in the know.
OncNet Newsletter